
Our Core Leadership
Therapies and Products at Better Health Corp
COVID LONG HAULT
BHC has acquired exclusive license rights of a patent pending nutraceutical formulation for the successful treatment of “Covid Long Haul”. Being verified by researchers, patient advocates and thought leaders; BHC has developed a product, COVID LONG HAULT®, that replenishes NAD+ and supports recovery from oxidative stress, key mechanisms that are responsible for the long term COVID19 symptoms; which leads to people in getting their lives back.
Therapies and Products at
Better Health Corp
COVID LONG HAULT
BHC has acquired exclusive license rights of a patent pending nutraceutical formulation for the successful treatment of “Covid Long Haul”. Being verified by researchers, patient advocates and thought leaders; BHC has developed a product, COVID LONG HAULT®, that replenishes NAD+ and supports recovery from oxidative stress, key mechanisms that are responsible for the long term COVID19 symptoms; which leads to people in getting their lives back.
Mitzva Wellness
Precision Cannabinoid Therapeutics
Mitzva Wellness Precision Cannabinoid Therapeutics BHC’s acquisition of a boutique Kosher CBD Brand is best known for treatment of Autism and other neurological indications.
BHC’s Science Advisory Board, led by world renowned endocannabinoid researcher, Alexandros Makriyannis, Ph.D. and with expertise of BHC, the Mitzva brand has evolved. Therapeutic based cannabinoids and terpene profiles will sustain revenues by expanding product line utilizing digital educational and promotion campaigns.
Read MoreScience Advisors
Get in touch with us.
Want to get in touch? We'd love to hear from you. Here's how you can reach us...